
|Articles|September 5, 2014
The Transatlantic Trade and Investment Partnership: From Hot TTIP to Oblivion?
Author(s)Reflector
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.
Advertisement
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean. TTIP, the Transatlantic Trade and Investment Partnership, was the hot tip for a 2014 success story. But as summer slides away and autumn beckons, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP now risks being tipped into oblivion.
For the rest of this article,
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
3
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
4
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
5




